Single‐center determination of reference factor II and factor X activity level values for the monitoring of vitamin K antagonist therapy
Stéphanie Desage(Laboratoire National de Référence), Yohann Jourdy(Université Claude Bernard Lyon 1), Christophe Nougier(Hospices Civils de Lyon), Sandra Le Quellec(Hospices Civils de Lyon), Claude Négrier(Unknown), Emilie Jousselme(Hospices Civils de Lyon)
Cited by 2
Related Papers
ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families.
|PubMed|1999|92
Utilization of Previously Treated Patients (PTPs), Noninfected Patients (NIPs), and Previously Untreated Patients (PUPs) in the Evaluation of New Factor VIII and Factor IX Concentrates
|Thrombosis and Haemostasis|1999|61
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome
|Blood|2020|60
Reccurrent F8 Intronic Deletion Found in Mild Hemophilia A Causes Alu Exonization
|The American Journal of Human Genetics|2018|29
Splicing analysis of 26 <i>F8</i> nucleotide variations using a minigene assay
|Haemophilia|2019|17